Sollievo Pharmaceuticals, Inc — Form C/A (Regulation Crowdfunding)
Sollievo Pharmaceuticals, Inc of SAN JUAN CAPISTRANO, CA filed a Form C/A (Regulation Crowdfunding) with the SEC on 2022-11-15. Target raise $10K, up to $1.1M. Offered through StartEngine Capital, LLC.
Offering
- Filed: 2022-11-15
- Form: C/A
- Accession: 0001665160-22-002919
- Target amount: $10K
- Maximum amount: $1.1M
- Security type: Common Stock
- Securities offered: 5,000
- Price: $2.0000
- Deadline: 2022-12-16
- Funding portal / intermediary: StartEngine Capital, LLC
- Intermediary file number: 007-00007
Issuer
- CIK: 0001940381
- Website: http://sollievopharm.com
- Legal status: Corporation
- Organized in: CA
- Incorporated: 2018-02-23
- Address: 32452 SPYGLASS COURT, SAN JUAN CAPISTRANO, CA, 92675
- Employees: 1
Financials (as filed)
- Total assets (most recent): $153
- Cash (most recent): $153
- Net income (most recent): $-189K
- Net income (prior): $-1.2M
- Short-term debt: $772K
- Long-term debt: $1.3M
People (2)
| Name | Role | Location |
|---|
| Robert Schultz | CEO, President, Sole Director CFO/Principal Accounting Officer | Lincoln, NE |
| Robert K. Schultz | Chief Executive Officer | San Juan Capistrano, CA |
Reg CF filing history (6)
More